| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.00096 | 1 |